Tag: Sanofi
Sanofi India Board appoints Deepak Arora as its new Managing Director
Deepak brings over 30 years of experience in the Pharmaceutical & Healthcare industry across North America, Europe, Middle East and Africa
Emcure Pharma, Sanofi India ink exclusive pact to expand reach of...
While Sanofi will continue to own and manufacture these brands across its plants in India and internationally, Emcure will leverage its strengths to engage healthcare professionals
Dr Reddy’s & Sanofi Healthcare expand partnership to launch Beyfortus, a...
Beyfortus® (nirsevimab) is the first monoclonal antibody approved to protect all infants born during or entering their 1st Respiratory Syncytial Virus (RSV) season
Sartorius partners with Sanofi to pioneer Next-Gen Bioprocessing platform
Joint effort aims to usher in a new era of continuous downstream biomanufacturing, reducing costs and enhancing sustainability in drug production
Sanofi India & Emcure Pharma announce exclusive distribution partnership to broaden...
While SIL will continue to own, import, and manufacture these brands across Sanofi’s plants in India and internationally, Emcure will leverage its strengths to engage healthcare professionals
Medidata & Sanofi Vaccines extend collaboration to improve patient centricity &...
Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real time data capture
Sanofi India’s Type 1 Diabetes Social Impact Program with RSSDI delivering...
Improved access to care and management resulting in fewer episodes of hypoglycaemia and hyperglycaemia per week
Sanofi India registers 12% growth in operating profits in Q2 of...
The Company was largely able to maintain its gross margins, despite the NLEM impact
Sanofi’s biologic ‘Dupixent’ to treat atopic dermatitis gets approval in India
It is the first biologic medicine for the treatment of moderate-to-severe atopic dermatitis in adults whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable
Sanofi reaffirms commitment to rare diseases in India
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India